William Hughes, MD
Urology · Gulfport, MSNPI 1275021636
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,042 of the $7,998 with a category attached, or 75.6%. 34 manufacturers reported payments, led by Boston Scientific at 28.4% of the total. 2025 is the largest year on record at $3,623, 8.0 times the $451 reported in 2021.
Across 184 payments — averaging $43.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Coloplast$1K
- Procept Biorobotics Corporation$616
- Dendreon Pharmaceuticals LLC$596
- Johnson & Johnson$434
- Calyxo, Inc.$292
- plus $3K from 28 others
Across 1 payment — averaging $7000.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Cornerstone Urology Network, LLC$7K
What the payments were for
- Travel & lodging$1,80223%
- Food & beverage$6,04276%
- Education$1542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $2,274 |
| Coloplast | 28 | $1,074 |
| Procept Biorobotics Corporation | 3 | $616 |
| Dendreon Pharmaceuticals LLC | 12 | $596 |
| Johnson & Johnson | 14 | $434 |
| Calyxo, Inc. | 4 | $292 |
| Urogen Pharma, Inc. | 7 | $276 |
| Astellas Pharma US Inc | 10 | $260 |
| Endo USA, Inc. | 11 | $252 |
| Urovant Sciences Inc | 14 | $229 |
| Teleflex LLC | 4 | $226 |
| Pfizer | 9 | $200 |
| Olympus America Inc. | 5 | $190 |
| Sumitomo Pharma America, Inc. | 8 | $153 |
| Innovation Technologies Inc | 2 | $107 |
| Siemens Medical Solutions USA, Inc. | 1 | $92 |
| Endo Pharmaceuticals Inc. | 4 | $88 |
| Ferring Pharmaceuticals Inc. | 4 | $77 |
| KARL Storz Endoscopy-america | 1 | $65 |
| Bayer | 3 | $64 |
| Novartis | 3 | $58 |
| ABC Home Medical Supply, Inc. | 3 | $49 |
| Merck | 2 | $45 |
| Progenics Pharmaceuticals, Inc. | 2 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $38 |
| Tolmar, Inc. | 2 | $33 |
| Antares Pharma, Inc. | 2 | $32 |
| Steris Corporation | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Profound Medical Corp. | 1 | $20 |
| Civco Medical Instruments | 1 | $19 |
| Telix Pharmaceuticals | 1 | $17 |
| Vertex | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700$1,712
- AQUABEAM SYSTEM$601
- PROVENGE$392
- TITAN$332
- CVAC Aspiration System$245
- JELMYTO$138
- URETERO-RENO VIDEOSCOPE$126
- UroLift$122
How this compares
$7,998 in reported general payments places this provider in the 80th percentile of 94 urology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 32 | $455,905 |
| XtandiEnzalutamide | 14 | $189,833 |
| OrgovyxRelugolix | 36 | $94,252 |
| MyrbetriqMirabegron | 62 | $35,226 |
| GemtesaVibegron | 27 | $17,029 |
| Estradiol | 67 | $4,248 |
| Tamsulosin Hcl | 209 | $2,493 |
| Finasteride | 111 | $1,953 |
| Testosterone Cypionate | 22 | $1,323 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 63 | $1,000 |
| Solifenacin Succinate | 18 | $546 |
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $527 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 43 | $510 |
| Cephalexin | 27 | $309 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $434 | $455,90532 claims |
| Astellas Pharma US IncXtandi, Myrbetriq | $260 | $225,05976 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $153 | $111,28263 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 94 urology providers in Mississippi.
Other urology in Gulfport
- Paige WhiteGulfport$7K
- Joseph CottoneGulfport$6K
- Jacob JornsGulfport$4K
- Sean DouglasHattiesburg$40K
- Robert HollabaughSouthaven$17K
- Kristopher WhiteheadTupelo$17K
- Harold BlalockJackson$15K
- Jon PoseyTupelo$13K
- Paul FarabaughTupelo$13K
- Clarance FarmerTupelo$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.